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Abstract: Significance tests and the corresponding p-values play a crucial role in decision making. In this commentary 
the meaning, interpretation and misinterpretation of p-values is presented. Alternatives for evaluating the reported evi-
dence are also discussed.  
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INTRODUCTION 
  Evidence-based medicine aims to apply scientific infor-
mation retrieved from the research to certain parts of medical 
practice. Particularly, it seeks to assess the quality of evi-
dence relevant to the risks and benefits of individuals’ char-
acteristics or treatments [1]. According to the Centre for 
Evidence-Based Medicine, "Evidence-based medicine is the 
conscientious, explicit and judicious use of current best evi-
dence in making decisions about the care of individual pa-
tients" [2]. A cornerstone in evidence-based medicine is de-
cision quality. Under the concept of evidence-based medi-
cine the research is categorized and ranked according to the 
strength of the lack from various biases. The strongest evi-
dence for therapeutic interventions is provided by meta-
analyses of randomized, double-blind, controlled clinical 
trials. On the contrary, case reports and expert opinion have 
little value. The U.S. Preventive Services Task Force [1] 
ranks scientific evidence in the following order: (a) Evidence 
obtained from more than one randomized controlled trials 
(Level I); (b) Evidence obtained from controlled trials 
without randomization (Level II-1); or Evidence obtained 
from prospective or case-control epidemiologic studies 
(Level II-2); or Evidence obtained from multiple time series 
with or without the intervention (Level II-3); and (c) 
Opinions of respected authorities, based on clinical 
experience, descriptive studies, or reports of expert 
committees (Level III). The UK National Health Service 
uses a similar system with categories labeled A, B, C, and D. 
Anytime a selection must be made among several alternative 
choices, a decision is being made, and the role of the re-
searcher is to assist in this process. Especially, when deci-
sions are complicated and require careful consideration and 
systematic review of the available information, the re-
searcher’s role becomes paramount.  
  Evidence-based medicine attempts to express clinical 
research using mathematical methods. Tools used by 
researchers include: the likelihood ratios, various (univariate 
or multivariate) statistical tests, the area under the receiver 
operator characteristic curve (ROC) and many others. The  
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p-value is one of the most widely used statistical terms in 
decision making in biomedical research, which assists the 
investigators to conclude about the significance of a research 
consideration. Up today, most researchers base their decision 
on the value of the probability p. However, the term p-value 
is often miss- or over- interpreted, leading to serious 
methodological errors and misinterpretations [3]. In this 
article the interpretation of the p-value and some alternatives 
options are discussed. 
DEFINITION OF THE P-VALUE 
  In statistical science, the p-value is the probability of 
obtaining a result at least as extreme as the one that was 
actually observed in the biological or clinical experiment or 
epidemiological study, given that the null hypothesis is true 
[4]. The testing of hypothesis is fundamental in statistics, 
and it could be considered as a “method” of making 
statistical decisions using experimental data. At this point we 
have to introduce some terms regarding hypothesis testing. 
There are two hypotheses, the null and the alternative. 
Usually, the null hypothesis that indicates no association 
between the investigated factors or characteristics (measured 
using random variables), e.g., “the prevalence of cardiovas- 
cular disease is equal between males and females”; thus, 
“there is no association between gender and the disease”. On 
the other hand, the alternative hypothesis indicates an 
association between the investigated variables (i.e. the 
prevalence of cardiovascular disease differs between genders 
(two-sided hypothesis), or the prevalence of males is greater 
than the prevalence of females or the prevalence of females 
is greater than the prevalence of males (one-sided 
hypothesis). In the 1950s, Fisher [5] proposed significance 
tests as a means of examining the discrepancy between the 
data and the null hypothesis. Some of the most often used 
significance tests in biomedical research are: the Z-test, the 
Student’s t-test, the F-test and the chi-square among others.  
  In statistical theory, the p-value is a random variable de-
fined over the sample space (i.e. the set of all possible out-
comes) of the experiment, such that its distribution under the 
null hypothesis is uniform on the interval (0, 1). For exam-
ple, a phase III clinical trial (experiment) is performed to 
determine if total cholesterol levels differ between the group  
that was under drug A treatment, compared with the group 
that was under drug B treatment. For simplicity, it is as-98    The Open Cardiovascular Medicine Journal, 2008, Volume 2  Demosthenes B. Panagiotakos 
sumed that baseline levels of cholesterol were equal, and 
after 12 months of treatment a mean absolute reduction on 
total cholesterol levels of 27±10 mg/dl was observed in 
group A and a mean absolute reduction of 25±10 mg/dl was 
observed in group B. If 100 patients were allocated to each 
treatment arm, and taking into account the assumptions of 
the appropriate significance test, the p-value of this hypothe-
sis testing is equal to 0.15. In this case the null hypothesis is 
that “in the population the mean absolute reductions were 
equal” against the alternative were “in the population the 
mean absolute reductions were not equal”. The p-value of 
this result is the chance of observing a 2 mg/dl difference 
between the two treatment arms, under the context that a 
similar reduction on cholesterol levels exists (i.e., the null 
hypothesis). The p-value of 0.15, means that the observed 
difference can be attributed to chance by 15%. In Fisher’s 
approach the null hypothesis is never proved, but is possibly 
disproved. Moreover, Fisher suggested 0.05 as a threshold of 
significance (i.e., ); if the p-value is less than , there is 
evidence to reject the null hypothesis. However, there has 
been considerable criticism about this choice, and its useful-
ness. Despite the criticisms made, all agree that the signifi-
cance level should be decided before the data are viewed, 
and is compared against the p-value after the test has been 
performed. Moreover, although p-values are widely used, 
there are several misunderstandings. In the text below, an 
attempt is made to clarify what the p-value really is and what 
it is not. 
WHAT THE P-VALUE IS AND WHAT IT IS NOT. 
 The  p-value is not the probability that the null hypothesis 
is true, and this is because hypotheses do not have probabili-
ties in classical statistics. Moreover, the p-value is not the 
probability of falsely rejecting the null hypothesis. Falsely 
rejecting the mull hypothesis is a Type I error. This error is a 
version of the so-called “prosecutor's fallacy”. The Type I 
error rate is closely related to the p-value since we reject the 
null hypothesis when p-value is less than a pre-defined level, 
. The p-value does not indicate the size or importance of the 
observed effect. Thus, a very small p-value, let say 0.000… 
(usually presented as <0.001) does not necessarily mean a 
strong association (compared with effect size which is a 
measure of the strength of the relationship between 2 vari- 
ables, e.g. odds ratio, relative risk, correlation coefficient, 
Cohen’s d etc [5, 6]). Moreover, the p-value is influenced by 
sample size. For example, the Fig. (1) illustrates the 
impressive decrease in p-value according to sample size, 
keeping the observed findings constant. It can be seen that if 
the initial sample size is doubled (i.e. n=200 per treatment 
arm) the study’s results achieve significance.  
  Another major issue that influences medical decision 
making is the multiple comparisons problem which occurs 
when a family of statistical inferences is considered simul- 
taneously. For example, with just one hypothesis test perfor- 
med at 5% significance level, there is only a 5% probability 
of obtaining a result at least as extreme as the one that was 
observed when the null hypothesis is true. However, with 
100 tests performed with all null hypotheses being true, it is 
more likely that at least one null hypothesis will be rejected. 
These errors are called false positives, and many mathema- 
tical techniques have been developed to control them. Most 
of these techniques modify the significance level , in order 
to account for the inflation of type I error rate and make the 
comparison of p-value more accurate. 
  For all the aforementioned reasons, many Journals have 
long been recommended to the authors to present confidence 
intervals instead of p-values since they are not considered 
mathematically sound [7]. 
 Finally,  the  p-value is not the probability that the 
experiment would not yield the same conclusion after 
replications. For this reason Killeen [8] proposed prep as a 
statistical alternative to the p-value, which calculates the 
probability of replicating an effect. An approximate of the 
prep is the following: 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Theoretical example of p-values in relation to sample size for the same difference in the data. 
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 The  lower  the  p-value is, the higher the prep. The Associa-
tion for Psychological Science (APS) recommends to con-
tributing authors of journals to present prep instead of p-
values. However, considerable criticism has been made. For 
example, prep does not take prior probabilities into account 
[9], and does not bring any additional information on the 
significance of the result of a given experiment. 
  Recently, Ioanndis [10] suggested that more “detailed” 
statistical methods should be applied, like Bayes factor B, to 
interpret ‘‘significant’’ associations. In general, Bayesian 
inference is a method for determining
 how scientific belief 
should be modified by observed data. Most important, Bayes 
factors require the addition
 of background knowledge to be 
transformed into inferences. The simplest form of Bayes 
factor is
 the likelihood ratio (i.e., the ratio  of the maximum 
probability of a result under two different hypotheses, the 
null where no associations are observed and the alternative). 
The minimum Bayes factor is
 objective and can be used in-
stead of p-value as a measure
  of the evidential strength. 
However, medical researchers have not been so enthusiastic 
to understand and adopt that Bayesian statistical methodolo-
gies perceive a subjective approach
 to evidence-based analy-
sis. Despite the criticism, for many scientists the use of Bays 
factor B is an alternative to the classical hypothesis testing 
mentioned above. Particularly, as Ioannides observed, when 
the factor B was calculated on 272 observational studies and 
50 meta-analyses on gene-disease associations (752 studies) 
for which statistically significant associations had been 
claimed (p<0.05), statistically significant results offered less 
than strong support to the credibility for 54–77% of the epi-
demiologic associations and 44–70% of the 50 associations 
from genetic meta-analyses [10].  
  In brief, unlike p-values, Bayes factors have
 a sound in-
terpretation that allows
 their use in both inference and deci-
sion making, since they make the distinction
 clear between 
experimental evidence and inferential conclusions
 while pro-
viding a framework in which to combine prior with current
 
evidence. 
CONCLUDING REMARKS 
  In this article an attempt was made to interpret the 
meaning of p-value, a probability that is the basis, in most 
biomedical research, of decision making. Recent guidelines 
for presenting the results of clinical experiments or 
observational studies, suggest providing confidence intervals 
instead or together with the p-values, and giving the effect 
sizes of the investigated associations. Nevertheless, the p-
value still has significant value when correctly interpreted 
and used. 
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